发明名称 |
BINDING MOLECULES FOR BCMA AND CD3 |
摘要 |
The present invention relates to a binding molecule comprising a first and a second binding domain, wherein the first binding domain is capable of binding to epitope clusters of BCMA, and the second binding domain is capable of binding to the T cell CD3 receptor complex. Moreover, the invention provides a nucleic acid sequence encoding the binding molecule, a vector comprising said nucleic acid sequence and a host cell transformed or transfected with said vector. Furthermore, the invention provides a process for the production of the binding molecule of the invention, a medical use of said binding molecule and a kit comprising said binding molecule. |
申请公布号 |
US2014348837(A1) |
申请公布日期 |
2014.11.27 |
申请号 |
US201214358520 |
申请日期 |
2012.11.15 |
申请人 |
Amgen Research (Munich) GmbH ;Boehringer Ingelheim International GmbH |
发明人 |
Kufer Peter;Raum Tobias;Hoffmann Patrick;Kischel Roman;Lutterbuese Ralf;Rau Doris;Adam Paul;Borges Eric;Hebeis Barbara;Hipp Susanne |
分类号 |
C07K16/28 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
1. A binding molecule which is at least bispecific comprising a first and a second binding domain, wherein
(a) the first binding domain is capable of binding to epitope cluster 3 and to epitope cluster 4 of BCMA; and (b) the second binding domain is capable of binding to the T cell CD3 receptor complex; and wherein epitope cluster 3 of BCMA corresponds to amino acid residues 24 to 41 of the sequence as depicted in SEQ ID NO: 1002, and epitope cluster 4 of BCMA corresponds to amino acid residues 42 to 54 of the sequence as depicted in SEQ ID NO: 1002. |
地址 |
Munch DE |